Showing results (1-10 of 543) with videos related to

Sort By:
Pageof 55
Cephalalgia : an International Journal of Headache|April 16, 2019
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled studyPeter J Goadsby, Koen Paemeleire, Gregor Broessner, et al.
The New England Journal of Medicine|November 25, 2017
A Controlled Trial of Erenumab for Episodic MigrainePeter J Goadsby, Uwe Reuter, Yngve Hallström, et al.
Neurology|July 9, 2020
One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE studyPeter J Goadsby, Uwe Reuter, Yngve Hallström, et al.
Cephalalgia : an International Journal of Headache|November 24, 2020
A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine preventionMessoud Ashina, David Doležil, Jo H Bonner, et al.
The Journal of Headache and Pain|August 5, 2020
Efficacy and safety of erenumab in women with a history of menstrual migraineJelena M Pavlovic, Koen Paemeleire, Hartmut Göbel, et al.
Headache|August 28, 2020
The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving ≥50%, ≥75%, and 100% ResponseGregor Broessner, Uwe Reuter, Jo H Bonner, et al.
Cephalalgia : an International Journal of Headache|August 9, 2018
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumabDawn C Buse, Richard B Lipton, Yngve Hallström, et al.
Cephalalgia : an International Journal of Headache|February 24, 2018
ARISE: A Phase 3 randomized trial of erenumab for episodic migraineDavid W Dodick, Messoud Ashina, Jan Lewis Brandes, et al.
Neurology|August 25, 2017
Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label studyMessoud Ashina, David Dodick, Peter J Goadsby, et al.
Neuron|March 9, 2004
Migraine aura: a knockin mouse with a knockout messagePeter J Goadsby
Pageof 55